Kinetics of anti-blood type isoagglutinin titers and B lymphocytes in ABO-incompatible living donor liver transplantation with rituximab and plasma exchange

Transplantation

Volumn 92, Issue 10, 2011, Pages 1134-1139

  Uchiyama, Hideaki ^a   Mano, Yohei ^a   Taketomi, Akinobu ^a   Soejima, Yuji ^a   Yoshizumi, Tomoharu ^a   Ikegami, Toru ^a   Shirabe, Ken ^a   Maehara, Yoshihiko ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

ABO incompatible; Allograft rejection; Isoagglutinin mediated rejection; Living donor liver transplantation; Plasma exchange; Rituximab

Indexed keywords

AGGLUTININ; CD19 ANTIGEN; GANCICLOVIR; IMMUNOGLOBULIN; RITUXIMAB; STEROID;

ACUTE GRAFT REJECTION; ARTICLE; B LYMPHOCYTE; BLOOD GROUP A; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP B; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DRUG MEGADOSE; FOLLOW UP; GRAFT SURVIVAL; HEPATITIS C; HUMAN; HUMAN TISSUE; KIDNEY GRAFT REJECTION; LIVER BIOPSY; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LIVING DONOR; PLASMAPHERESIS; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; SPLENECTOMY; VIREMIA;

ABO BLOOD-GROUP SYSTEM; ADULT; AGED; AGGLUTININS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; ANTIGENS, VIRAL; B-LYMPHOCYTES; BLOOD GROUP INCOMPATIBILITY; FEMALE; HEPATITIS C; HUMANS; KINETICS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; PLASMA EXCHANGE; RNA, VIRAL;

EID: 80855123587     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318231e9f8     Document Type: Article

References (29)

1. Raut V, Uemoto S. Management of ABO-incompatible living-donor liver transplantation: Past and present trends. Surg Today 2011; 41: 317.
2. Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers. Lancet 1990; 336: 519.
3. Demetris AJ, Jaffe R, Tzakis A, et al. Antibody-mediated rejection of human orthotopic liver allografts. A study of liver transplantation across ABO blood group barriers. Am J Pathol 1988; 132: 489.
4. Egawa H, Teramukai S, Haga H, et al. Present status of ABOincompatible living donor liver transplantation in Japan. Hepatology 2008; 47: 143.
5. Ikegami T, Taketomi A, Soejima Y, et al. Successful ABO incompatible living donor liver transplantation in a patient with high isoagglutinin titer using high-dose intravenous immunoglobulin. Transplant Proc 2007; 39: 3491.
6. Morioka D, Togo S, Kumamoto T, et al. Six consecutive cases of successful adult ABO-incompatible living donor liver transplantation: A proposal for grading the severity of antibody-mediated rejection. Transplantation 2008; 85: 171.
7. Jordan SC, Vo AA, Peng A, et al. Intravenous gammaglobulin (IVIG):A novel approach to improve transplant rates and outcomes in highly HLA-sensitized patients. Am J Transplant 2006; 6: 459.
8. Vo AA, Lukovsky M, Toyoda M, et al. Rituximab and intravenous immune globulin for desensitization during renal transplantation. N Engl J Med 2008; 359: 242.
9. Ikegami T, Taketomi A, Soejima Y, et al. Rituximab, IVIG, and plasma exchange without graft local infusion treatment: A new protocol in ABO incompatible living donor liver transplantation. Transplantation 2009; 88: 303.
10. Ishida H, Koyama I, Sawada T, et al. Anti-AB titer changes in patients with ABO incompatibility after living related kidney transplantations: Survey of 101 cases to determine whether splenectomies are necessary for successful transplantation. Transplantation 2000; 70: 681.
11. Hanto DW, Fecteau AH, Alonso MH, et al. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: Evidence for accommodation. Liver Transpl 2003; 9: 22.
12. Tanaka Y, Haga H, Egawa H, et al. Intragraft expression of recipienttype ABO blood group antigens: Long-term follow-up and histological features after liver transplantation. Liver Transpl 2005; 11: 547.
13. Tanabe T, Ishida H, Horita S, et al. Decrease of blood type antigenicity over the long-term after ABO-incompatible kidney transplantation. Transpl Immunol 2011; 25: 1.
14. Genberg H, Hansson A, Wernerson A, et al. Pharmacodynamics of rituximab in kidney allotransplantation.AmJ Transplant 2006; 6: 2418.
15. Egawa H, Ohmori K, Haga H, et al. B-cell surface marker analysis for improvement of rituximab prophylaxis in ABO-incompatible adult living donor liver transplantation. Liver Transpl 2007; 13: 579.
16. Tanabe M, Kawachi S, Obara H, et al. Current progress in ABOincompatible liver transplantation. Eur J Clin Invest 2010; 40: 943.
17. Egawa H, Oike F, Buhler L, et al. Impact of recipient age on outcome of ABO-incompatible living-donor liver transplantation. Transplantation 2004; 77: 403.
18. Kozaki K, Egawa H, Kasahara M, et al. Therapeutic strategy and the role of apheresis therapy for ABO incompatible living donor liver transplantation. Ther Apher Dial 2005; 9: 285.
19. Shapiro-Shelef M, Calame K. Regulation of plasma-cell development. Nat Rev Immunol 2005; 5 230.
20. Kim SH, Lee JM, Choi JY, et al. Changes of portosystemic collaterals and splenic volume on CT after liver transplantation and factors influencing those changes. AJR Am J Roentgenol 2008; 191: W8.
21. Jeng LB, Lee CC, Chiang HC, et al. Indication for splenectomy in the era of living-donor liver transplantation. Transplant Proc 2008; 40: 2531.
22. Yoshizumi T, Taketomi A, Soejima Y, et al. The beneficial role of simultaneous splenectomy in living donor liver transplantation in patients with small-for-size graft. Transpl Int 2008; 21: 833.
23. Ikegami T, Soejima Y, Taketomi A, et al. Hypersplenism after living donor liver transplantation. Hepatogastroenterology 2009; 56: 778.
24. Kishi Y, Sugawara Y, Akamatsu N, et al. Splenectomy and preemptive interferon therapy for hepatitis C patients after living-donor liver transplantation. Clin Transplant 2005; 19: 769.
25. Haga H, Egawa H, Shirase T, et al. Periportal edema and necrosis as diagnostic histological features of early humoral rejection in ABOincompatible liver transplantation. Liver Transpl 2004; 10: 16.
26. Haga H, Egawa H, Fujimoto Y, et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl 2006; 12: 457.
27. Soejima Y, Taketomi A, Yoshizumi T, et al. Biliary strictures in living donor liver transplantation: Incidence, management, and technical evolution. Liver Transpl 2006; 12: 979.
28. Uchiyama H, Harada N, Sanefuji K, et al. Dual hepatic artery reconstruction in living donor liver transplantation using a left hepatic graft with 2 hepatic arterial stumps. Surgery 2010; 147: 878.
29. Morioka D, Sekido H, Kubota K, et al. Antibody-mediated rejection after adult ABO-incompatible liver transplantation remedied by gamma-globulin bolus infusion combined with plasmapheresis. Transplantation 2004; 78: 1225.